Joe started out as a consultant for Generex many years ago
Joe started out as a consultant for Generex many years ago when former CEO Gluskin was about to bankrupt Generex. She could no longer raise any capital, her toxic death spiral financings strangled every aspect of the company, including signing Ii-Key patents as collateral to Crenshaw Capital etc. Joe at that moment found Anna new rounds of investors, that were at least enough to start to clean out the horrible mess she caused. But he wasn’t an executive or on the BOD, do he called no shots as other like Bill Abajian steered Anna in weird directions. Joe later worked with her replacement to fix to huge aspects harming the company, odd real estate and alleged illicit financial dealings by a former executive, as well as taking a comprehensive review of Generex’s clinical trials.
Joe brought on Dr Anderson a former LLY executive who originally brought GNBT and LLY together before Anna blew that deal. He started completely redesigning the Oral-lyn formulation which is ready for new studies per funding. Joe brought in Dr Craig Eagle from PFE who took an expert look at the AE37 protocol designed by Col George Peoples from Walter Reed and found it flawed. Eagle and Joe convinced Generex to make a new protocol putting in more low her2 expressing patients since the study had far too many high her2 expressing patients who then are already on the exceptional Herceptin. That move saved enough of the study to mark significant disease free survival improvement in triple negative patients to move into a key study with Keytruda. Once Covid allows for these patients to get back into studies at the Cleveland Clinic that one can be wrapped up.
Joe then became CEO after Fletcher crashed the company without even submitting sec filings for quarters. He put up his own money to get the filings submitted and Gnbt back on standing with the SEC.
As a consultant he did a lot, wasn’t in charge of the stupid decisions, and as CEO has worked to accomplish a lot.
That’s the real history leading into a future because Joe saved Generex and AE37.
10
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...
Continue Reading
New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...
Continue Reading
Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...
Continue Reading
End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...
Continue Reading
The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...
Continue Reading
A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...
Continue Reading
The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...
Continue Reading
A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...
Continue Reading
Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...
Continue Reading
A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...
Continue Reading
Top 5 Most Recently Viewed Articles
Ageas Highlights Progress in Share Buy-Back Programme Ageas shares exciting news regarding its ongoing share buy-back programme that aims to enhance shareholder value and strengthen the company’s market position. Officially launched, this programme is designed to repurchase shares under favorable market conditions. Recent Purchases and Financial Overview From the...
Continue Reading
Understanding the Latest Crude Oil Inventory Trends The Energy Information Administration (EIA) has recently published a report detailing the latest shifts in crude oil inventories. This report reveals a smaller-than-forecast decline in the volume of crude oil held by U.S. companies, with the actual decrease reported at only 0.934 million barrels. What This Means for the...
Continue Reading
Annexon Highlights Positive Topline Results for ANX005 in GBS Annexon, Inc. (Nasdaq: ANNX), a pioneer in developing innovative treatments for debilitating neuroinflammatory diseases, has announced promising topline results from a recent real-world evidence (RWE) study. This study strongly supports the efficacy of ANX005, a groundbreaking therapy for Guillain-Barré...
Continue Reading
Amer Sports Inc. Hits New Heights with Solid Earnings Growth Amer Sports, Inc. (NYSE: AS) has made headlines recently as its stock price increased significantly following an impressive third quarter performance. The company reported earnings and sales that surpassed Wall Street's expectations, benefiting from robust double-digit growth across all regions and segments. The...
Continue Reading
Understanding the Class Action Lawsuit Against Rocket Companies Pomerantz LLP has announced an important development regarding Rocket Companies, Inc. (NYSE: RKT). A class action lawsuit is currently pending, and it serves as a significant alert for investors who may have sustained losses on their investments in Rocket. If you've purchased securities in this company during...
Continue Reading